Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine Dose Response in Fibromyalgia
NCT00190866Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Jun 2005
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of duloxetine in fibromyalgia (FM), sponsored by Eli Lilly and Company. Started Jun 2005; status: completed.
02
Drugs
duloxetine
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT00190866.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00190866.